Reaction Details | |||
---|---|---|---|
Report a problem with these data | |||
Target | Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit alpha isoform | ||
Ligand | BDBM50433042 | ||
Substrate/Competitor | n/a | ||
Meas. Tech. | ChEMBL_955790 (CHEMBL2379607) | ||
Ki | 6.9±n/a nM | ||
Citation | Cheng, H; Hoffman, JE; Le, PT; Pairish, M; Kania, R; Farrell, W; Bagrodia, S; Yuan, J; Sun, S; Zhang, E; Xiang, C; Dalvie, D; Rahavendran, SV Structure-based design, SAR analysis and antitumor activity of PI3K/mTOR dual inhibitors from 4-methylpyridopyrimidinone series. Bioorg Med Chem Lett23:2787-92 (2013) [PubMed] Article | ||
More Info.: | Get all data from this article, Assay Method | ||
Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit alpha isoform | |||
Name: | Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit alpha isoform | ||
Synonyms: | PI3-kinase p110 subunit alpha | PI3-kinase p110-alpha subunit | PI3K | PK3CA_MOUSE | Phosphatidylinositol 3-kinase p110α (p110α) | Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit alpha isoform (PI3K alpha) | Phosphatidylinositol-4,5-bisphosphate 3-kinase catalytic subunit alpha isoform | Pik3ca | PtdIns-3-kinase p110 | ||
Type: | Protein | ||
Mol. Mass.: | 124421.84 | ||
Organism: | Mus musculus (Mouse) | ||
Description: | P42337 | ||
Residue: | 1068 | ||
Sequence: |
| ||
BDBM50433042 | |||
n/a | |||
Name | BDBM50433042 | ||
Synonyms: | CHEMBL2375962 | ||
Type | Small organic molecule | ||
Emp. Form. | C19H23N7O3 | ||
Mol. Mass. | 397.431 | ||
SMILES | Cc1nc(N)nc2n([C@@H]3CC[C@@H](CC3)OCC(N)=O)c(=O)c(cc12)-c1cn[nH]c1 |r,wD:8.7,11.14,(43.18,-30.37,;43.19,-31.91,;41.86,-32.68,;41.85,-34.23,;40.52,-34.99,;43.19,-35,;44.52,-34.23,;45.86,-35.01,;45.85,-36.54,;47.18,-37.31,;47.17,-38.86,;45.83,-39.62,;44.5,-38.84,;44.51,-37.31,;45.82,-41.16,;44.48,-41.92,;43.15,-41.14,;41.81,-41.9,;43.16,-39.6,;47.21,-34.23,;48.54,-35.01,;47.21,-32.68,;45.86,-31.89,;44.52,-32.67,;48.55,-31.92,;49.94,-32.56,;50.98,-31.43,;50.22,-30.09,;48.71,-30.4,)| | ||
Structure |